Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BU.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BQ.1.23ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BA.1.9ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
XSORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
BM.1.1.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5491.88Germany
B.1.1.74NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.1.267NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.1.444NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.51ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-5424.4Singapore
GM.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-5385.48Hong Kong
JN.1.65ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-5377.88China
HK.24.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-5377.88China
GK.2.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-5377.88China
JN.1.1.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5370.98Germany
GK.1.11.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5370.98Germany
B.1.267NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5370.98Germany
B.1.537NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5370.98Germany
B.1.177.49NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5370.98Germany
BA.5.2.24ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5365.32Germany
B.19NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-5354.24US
FY.4.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-5343.67Japan
LE.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
XBB.1.11.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
XBB.1.5.28ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
XBB.2.6ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
BR.2.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
EU.1.1.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
XBB.1.5.80ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
GD.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
JN.1.30ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
EG.5.1.13ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
B.1.287ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
B.1.1.27ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
B.1.1.516ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
FL.13.3.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
B.1.1.424ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
FL.10.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
B.1.1.348ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
BF.5ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-5342.9France
XAY.2.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5308.94Japan
CH.1.1.12SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
FL.32.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
XBB.1.28SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
BM.4.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
FC.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
FL.39.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
AY.4.10 (Delta)SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
KW.1.1.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
unclassifiableSNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
XDNSNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used